Global Assessment Study of Anti-cholinergics on Efficacy and Tolerability for Patients with OAB
- Conditions
- Overactive bladder
- Registration Number
- JPRN-UMIN000003033
- Lead Sponsor
- GAP Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Not provided
(1)Genuine stress incontinence. (2)Prostate cancer, bladder cancer, urinary tract stones, symptomatic urinary tract infection, recurrent urinary tract infection and interstitial cystitis. (3)Indwelling or intermittent urethral catheterization. (4)Polyuria. (5)Lower urinary tract symptom is unstable. (6)Serious heart failure, serious liver failure and serious kidney failure. (7)Contraindications to antimusucarinic agents. (8)Sjogren's syndrome or hyposalivation by RT. (9)Treatment with banned medicine within 2 weeks before the run-in period. (10)Electric stimulation therapy or bladder training within 3 months before the run-in period. (11)Genitourinary surgery within 6 months before the run-in period. (12)Any other cases who are regarded as inadequate for study enrollment by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method